To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions

clinical trial

To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00861939

P6099clinical trial phasephase I clinical trialQ5452194
P582end time2004-04-01
P4135maximum age58
P2899minimum age18
P1132number of participants28
P4844research interventionbupropionQ834280
P8005research subject recruitment statuscompletedQ76651189
P859sponsorSandozQ528468
P580start time2004-03-01
P8363study typeinterventional studyQ78089383
P1476titleA Relative Bioavailability Study of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions

Search more.